Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
Pedro Perez, Vascular Consultant – PERT and VTE Program Builder at Argon Medical Devices, Inc., shared on LinkedIn:
”The VTE market is clearly entering its next phase
With Penumbra joining Boston Scientific and Inari becoming part of Stryker, the two category-defining innovators are now backed by global strategics with massive scale, capital, and contracting power.
These companies earned their leadership through time in market, differentiated technology, clinical evidence, and deep physician trust — advantages that are hard to replicate.
What does this mean for the rest of the field?
The VTE space is increasingly crowded, but the available market share is limited.
New and emerging competitors are fighting uphill for protocol inclusion, value analysis approval, workflow adoption, and mindshare in labs already standardized around established platforms.
We’re shifting from an innovation-first era to a scale, execution, and economic-value era.
Going forward, success won’t come from “me too” devices — it will come from clear clinical differentiation, operational simplicity, and undeniable total cost impact.
Consolidation isn’t slowing competition.
It’s raising the bar.”
Stay updated with Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis
-
Jan 22, 2026, 10:16Mohamed Rawy Gives Clinical Tips for Management of Atrial Fibrillation